Views

CrossRef citations to date

Altmetric

Coronaviruses

Novel dual multiplex real-time RT-PCR assays for the rapid detection of SARS-CoV-2, influenza A/B, and respiratory syncytial virus using the BD MAX open system

Hsing-Yi Chunga Division of Clinical Pathology, Department of Pathology, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan, ROCView further author information

Ming-Jr Jiana Division of Clinical Pathology, Department of Pathology, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan, ROCView further author information

Chih-Kai Changa Division of Clinical Pathology, Department of Pathology, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan, ROCView further author information

Jung-Chung Linb Division of Infectious Diseases and Tropical Medicine, Department of Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan, ROCView further author information

Kuo-Ming Yehb Division of Infectious Diseases and Tropical Medicine, Department of Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan, ROCView further author information

Chien-Wen Chenc Division of Pulmonary and Critical Care Medicine, Department of Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan, ROCView further author information

Sheng-Kang Chiub Division of Infectious Diseases and Tropical Medicine, Department of Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan, ROCView further author information

Yi-Hui Wanga Division of Clinical Pathology, Department of Pathology, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan, ROCView further author information

Shu-Jung Liaoa Division of Clinical Pathology, Department of Pathology, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan, ROCView further author information

Shih-Yi Lia Division of Clinical Pathology, Department of Pathology, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan, ROCView further author information

Shan-Shan Hsieha Division of Clinical Pathology, Department of Pathology, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan, ROCView further author information

Shih-Hung Tsaid Department of Emergency Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan, ROCView further author information

Cherng-Lih Pernga Division of Clinical Pathology, Department of Pathology, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan, ROCView further author information

Ji-Rong Yange Centers for Disease Control, Taipei, Taiwan, ROCView further author information

Ming-Tsan Liue Centers for Disease Control, Taipei, Taiwan, ROCView further author information

Feng-Yee Changb Division of Infectious Diseases and Tropical Medicine, Department of Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan, ROCView further author information

Hung-Sheng Shanga Division of Clinical Pathology, Department of Pathology, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan, ROCCorrespondence[email protected]
View further author information

show all

Figures & data

Figure 1. Experimental design for detecting SARS-CoV-2, influenza A/B and respiratory syncytial virus on the BD MAX System.

Table 1. Primer and probe sequences used for real-time RT-PCR detection of SARS-CoV-2, influenza A/B, and RSV.

Download CSV Display Table

Table 2. Limit-of-detection results for SARS-CoV-2, influenza A/B, and RSV on the BD MAX System.

Download CSV Display Table

Table 3. Positive and negative agreement of the Taiwan CDC lab-developed SARS-CoV-2 assay with the BD MAX platform SARS-CoV-2 assay.

Download CSV Display Table

Table 4. Proportions of specimens positive for non–SARS-CoV-2* respiratory pathogens.

Download CSV Display Table

Supplemental material

Supplementary_Table_1_and_2_2020_12_11.docx

Download MS Word (19.3 KB)

Novel dual multiplex real-time RT-PCR assays for the rapid detection of SARS-CoV-2, influenza A/B, and respiratory syncytial virus using the BD MAX open system

Table 1. Primer and probe sequences used for real-time RT-PCR detection of SARS-CoV-2, influenza A/B, and RSV.

Table 2. Limit-of-detection results for SARS-CoV-2, influenza A/B, and RSV on the BD MAX System.

Table 3. Positive and negative agreement of the Taiwan CDC lab-developed SARS-CoV-2 assay with the BD MAX platform SARS-CoV-2 assay.

Table 4. Proportions of specimens positive for non–SARS-CoV-2* respiratory pathogens.

Supplementary_Table_1_and_2_2020_12_11.docx

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Novel dual multiplex real-time RT-PCR assays for the rapid detection of SARS-CoV-2, influenza A/B, and respiratory syncytial virus using the BD MAX open system

Figures & data

Table 1. Primer and probe sequences used for real-time RT-PCR detection of SARS-CoV-2*, influenza A/B, and RSV*.

Table 2. Limit-of-detection results for SARS-CoV-2*, influenza A/B, and RSV* on the BD MAX System.

Table 3. Positive and negative agreement of the Taiwan CDC lab-developed SARS-CoV-2 assay with the BD MAX platform SARS-CoV-2 assay.

Table 4. Proportions of specimens positive for non–SARS-CoV-2* respiratory pathogens.

Supplementary_Table_1_and_2_2020_12_11.docx

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date

Table 1. Primer and probe sequences used for real-time RT-PCR detection of SARS-CoV-2, influenza A/B, and RSV.

Table 2. Limit-of-detection results for SARS-CoV-2, influenza A/B, and RSV on the BD MAX System.